Comparing treatment strategies using a synthesized clinical trial: an analysis of late versus early use of trimethoprim-sulfamethoxazole for AIDS patients.
From MaRDI portal
Publication:5939499
DOI10.1016/S0378-3758(00)00334-7zbMath1147.62384OpenAlexW1963825536MaRDI QIDQ5939499
David A. Schoenfeld, Dianne M. Finkelstein
Publication date: 26 September 2001
Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/s0378-3758(00)00334-7
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Estimation in survival analysis and censored data (62N02)
Cites Work
- Supremum Versions of the Log-Rank and Generalized Wilcoxon Statistics
- Estimating the superiority of a drug to a placebo when all and only those patients at risk are treated with the drug.
- Estimating a multiplicative treatment effect under biased allocation
- A nonidentifiability aspect of the problem of competing risks.
This page was built for publication: Comparing treatment strategies using a synthesized clinical trial: an analysis of late versus early use of trimethoprim-sulfamethoxazole for AIDS patients.